| |
引用文献のカテゴリー* |
引用文献名 及び一部の箇所が関連するときは、その関連する箇所の表示 |
関連する
請求項の番号 |
|
(1)
|
X
|
POLGE, C. et al., Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1, The FASEB Journal, 2011, Vol.25, pp.3790-3802 |
1-11
|
|
|
特に第３７９０頁要旨，第３７９１頁右欄第６行～下から第２６行，第３７９８頁右欄下から第９行～第３７９９頁左欄第３行
|
|
|
|
|
|
|
(2)
|
X
|
KIM, J. et al., p38 MAPK participates in muscle-specific RING Finger 1-mediated atrophy in cast-immobilized rat gastrocnemius muscle, The Korean Journal of Physiology and Pharmacology, 2009, Vol.13, pp.491-496 |
1-11
|
|
|
第４９１頁要旨，第４９１頁左欄第１行～右欄下から第７行，第４９２頁右欄第５行～第２５行，第４９５頁右欄第１行～第１２行
|
|
|
|
|
|
|
(3)
|
X
|
CHEN, B. et al., Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro, Acta Pharmacologica Sinica, 2010, Vol.31, pp.798-804 |
1-8
|
|
|
特に第７９８頁要旨，第７９９頁右欄第１９行～第２８行，第８０１頁左欄第６行～第１６行
|
|
|
A
|
|
9-11
|
|
|
|
|
|
(4)
|
X
|
CASTILLERO, E. et al., Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes, Metabolism Clinical and Experimental, 2013, Vol.62, pp.1495-1502 |
1-8
|
|
|
特に第１４９５頁要旨，第１４９６頁右欄第１行～第２６行，図４
|
|
|
A
|
|
9-11
|
|
|
|
|
|
(5)
|
X
|
ADAMS, V. et al., Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility, Cardiovascular Research, 2007, Vol.73, pp.120-129 |
1-8
|
|
|
第１２０頁要旨，第１２２頁右欄第１行～下から第１行
|
|
|
A
|
|
9-11
|
|
|
|
|
|
(6)
|
A
|
JP 2015-502365 A (オンコイミューニン，インコーポレイティド) 22.01.2015 (2015-01-22) |
7-11
|
|
|
|
|
|
|
|
|
|
(7)
|
A
|
JP 2009-518022 A (ピエール・ファーブル・デルモ－コスメティク) 07.05.2009 (2009-05-07) |
7-11
|
|
|
|
|
|
|
|
|
|
(8)
|
A
|
JP 2018-513668 A (日東電工株式会社) 31.05.2018 (2018-05-31) |
7-11
|
|
|
|
|